RSS   Newsletter   Contact   Advertise with us

Unilife appoints David Hastings as CFO

Staff writer | York, Pa., USA | January 13, 2015
UnilifeJanuary 13, 2015, York, Pa., USA - Unilife Corporation, a medical device company, announced the appointment of David Hastings as chief financial officer, on February 23, 2015.
Mr. Hastings most recently served as Chief Financial Officer at Incyte Corporation between 2003 and 2014. Mr. Hastings played an important role in Incyte's evolution from early stage drug discovery into a financially robust commercial business with an FDA approved oncology drug and a strong clinical pipeline.

During his 30 year career, including 15 years as a CFO in the biopharmaceutical industry, Mr. Hastings has held senior financial leadership roles at companies such as ArQule, Inc., Genzyme (now a wholly owned subsidiary of Sanofi), and PriceWaterhouseCoopers. He is a Certified Public Accountant.

Dennis Pyers, who has been with Unilife since 2010 will continue to serve as interim CFO until February 23rd, 2015, and will then remain at Unilife as Senior Vice-President and Controller.


 LATEST MOVES FROM Pennsylvania 


MORE INSIDE POST